ENO4 Inhibitors
ENO4 inhibitors represent a distinct class of chemical compounds designed to selectively impede the enzymatic activity of the protein ENO4. ENO4, a protein that presumably plays a critical role in a specific cellular process or signaling pathway, requires precise regulation for maintaining cellular homeostasis. Inhibitors targeting ENO4 are synthesized to bind with high specificity to the active site or to allosteric sites of the protein, thereby preventing its normal function. These inhibitors might work by mimicking the substrate of ENO4, effectively competing for the active site, or by inducing conformational changes in the protein structure that result in a decrease in its enzymatic activity. The design of such inhibitors is grounded in the detailed understanding of the protein's structure and the molecular interactions it engages in during the performance of its biological function.
The specificity of ENO4 inhibitors ensures that their impact is localized to the pathways directly involving the protein, minimizing off-target effects that are common with less targeted approaches. By focusing on the unique aspects of ENO4's role within the cell, these inhibitors can alter the protein's activity without necessarily affecting the broader functions of the cell. This alteration typically involves the interruption of a cascade of intracellular signals that ENO4 either initiates or propagates. The chemical structure of ENO4 inhibitors is such that they can effectively permeate cellular membranes to reach intracellular targets or bind to extracellular portions of ENO4 if it is a membrane-associated protein. Through these mechanisms, ENO4 inhibitors can achieve a potent and selective downregulation of the protein's activity, which could be crucial for regulating processes that are aberrant due to ENO4 dysregulation.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Dichloroacetic acid | 79-43-6 | sc-214877 sc-214877A | 25 g 100 g | $61.00 $128.00 | 5 | |
Dichloroacetate inhibits pyruvate dehydrogenase kinase, resulting in the activation of pyruvate dehydrogenase and decreasing the reliance of cells on glycolysis. Given that ENO4 is involved in the glycolytic pathway, decreasing glycolysis indirectly leads to reduced functional activity of ENO4. | ||||||
Lonidamine | 50264-69-2 | sc-203115 sc-203115A | 5 mg 25 mg | $105.00 $364.00 | 7 | |
Lonidamine selectively inhibits hexokinase, thereby reducing glucose utilization and ATP production through glycolysis. Reduced glycolytic flow would diminish the role of ENO4 in energy metabolism. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $70.00 $215.00 | 26 | |
2-Deoxy-D-glucose is taken up by cells and phosphorylated by hexokinase but cannot be further metabolized, thus inhibiting glycolysis. This leads to reduced ENO4 activity as the enzyme's involvement in glycolysis is decreased due to the blockage of the pathway. | ||||||
α-Cyano-4-hydroxycinnamic acid | 28166-41-8 | sc-254923 | 2 g | $43.00 | 2 | |
Alpha-cyano-4-hydroxycinnamate inhibits the mitochondrial pyruvate carrier, preventing pyruvate entry into the mitochondria and its subsequent oxidation. This shifts cellular metabolism away from oxidative phosphorylation to glycolysis, increasing lactate production and reducing the functional need for ENO4 activity. | ||||||
Phloretin | 60-82-2 | sc-3548 sc-3548A | 200 mg 1 g | $64.00 $255.00 | 13 | |
Phloretin inhibits various glucose transporters, reducing glucose uptake into cells. This limits the substrate availability for the glycolytic enzymes, including ENO4, thereby indirectly inhibiting its activity. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein inhibits tyrosine kinases and can alter multiple cell signaling pathways. By affecting these pathways, genistein can lead to a downregulation of glycolytic enzymes, including ENO4, thereby reducing its activity. | ||||||
Quercetin | 117-39-5 | sc-206089 sc-206089A sc-206089E sc-206089C sc-206089D sc-206089B | 100 mg 500 mg 100 g 250 g 1 kg 25 g | $11.00 $17.00 $110.00 $250.00 $936.00 $50.00 | 33 | |
Quercetin inhibits phosphoinositide 3-kinases and can reduce the activation of the Akt pathway, which is involved in glucose metabolism. This may lead to a downregulation of glycolytic enzymes, such as ENO4, and reduce its activity. | ||||||
Sodium Fluoride | 7681-49-4 | sc-24988A sc-24988 sc-24988B | 5 g 100 g 500 g | $40.00 $46.00 $100.00 | 26 | |
Sodium fluoride inhibits enolase enzymes by binding to the magnesium ion cofactor required for their activity. As ENO4 is an enolase, this would directly inhibit its activity. | ||||||
D-Galactose | 59-23-4 | sc-202564 | 100 g | $288.00 | 4 | |
Galactose can competitively inhibit glucose metabolism and when accumulated, it can reduce the efficiency of glycolysis. This would indirectly reduce the activity of glycolytic enzymes, including ENO4. | ||||||